These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy]. Kanda K; Waki S; Uchimura M; Kida H; Narita K; Harada N Gan To Kagaku Ryoho; 1990 Dec; 17(12):2421-4. PubMed ID: 2260877 [TBL] [Abstract][Full Text] [Related]
45. Treatment of metastatic renal cell carcinoma: review of experience and world literature. Luderer RC; Opipari MI; Perrotta AL J Am Osteopath Assoc; 1978 Apr; 77(8):590-603. PubMed ID: 649445 [No Abstract] [Full Text] [Related]
46. [On the medical treatment of metastases of hypernephroid cancer of the kidneys]. Evseenko LS; Orlova RS; Barsel' VA; Disvetova VV Vopr Onkol; 1966; 12(9):53-5. PubMed ID: 6004069 [No Abstract] [Full Text] [Related]
47. Value of liver function tests in the diagnosis of hepatic metastases in patients with gastric cancer. Cederqvist C; Nielsen J Acta Chir Scand; 1972; 138(6):604-8. PubMed ID: 5084304 [No Abstract] [Full Text] [Related]
51. [Increase in transaminases during treatment with danazol in lupus patients]. Vincens M; Athea N; Dougados M; Jungers P Therapie; 1984; 39(5):541-4. PubMed ID: 6506011 [No Abstract] [Full Text] [Related]
52. Scintigraphic evidence for the regression of skeletal metastases from a hypernephroma following long-term treatment with medroxyprogesterone acetate. Minervini R; Fiorentini L; Carlino F; Mazzuca N; Mariani G J Nucl Med Allied Sci; 1982; 26(1):55-9. PubMed ID: 6213743 [No Abstract] [Full Text] [Related]
53. Medroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma). Samuels ML; Sullivan P; Howe CD Cancer; 1968 Sep; 22(3):525-32. PubMed ID: 5673232 [No Abstract] [Full Text] [Related]
54. Role of hormones in growth kinetics of renal cell carcinoma in vitro. Cummings KB; Wheelis RF; Nelson FW J Urol; 1977 Mar; 117(3):269-71. PubMed ID: 839583 [TBL] [Abstract][Full Text] [Related]
55. Hormonal therapy in metastatic hypernephroma. Peterson LJ; Grimes JH; Dees JE; Anderson EE Urology; 1974 Dec; 4(6):669-73. PubMed ID: 4454105 [No Abstract] [Full Text] [Related]
56. The role of medroxyprogesterone acetate (MPA) in the treatment of renal adenocarcinoma. Kjaer M Cancer Treat Rev; 1988 Sep; 15(3):195-209. PubMed ID: 2974757 [No Abstract] [Full Text] [Related]
57. Hormones in the treatment of metastatic renal cancer. Morales A; Kiruluta G; Lott S J Urol; 1975 Nov; 114(5):692-3. PubMed ID: 1185861 [TBL] [Abstract][Full Text] [Related]
58. Chemotherapy with hydroxyurea (NSC-32065) in renal cell carcinoma. Nevinny HB; Hall TC J Clin Pharmacol J New Drugs; 1968; 8(6):352-9. PubMed ID: 4883783 [No Abstract] [Full Text] [Related]
59. [Complete regression of pulmonary metastases from renal cell carcinoma induced by medroxyprogesterone and streptococcal preparation: a case presentation]. Nagakura K; Takao M; Matsuzaki S; Ieda K Nihon Hinyokika Gakkai Zasshi; 1985 Dec; 76(12):1909-13. PubMed ID: 2940397 [No Abstract] [Full Text] [Related]